These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 38764070)
1. The safety profile of mesenchymal stem cell therapy administered through intrathecal injections for treating neurological disorders: a systematic review and meta-analysis of randomised controlled trials. Mesa Bedoya LE; Camacho Barbosa JC; López Quiceno L; Barrios Arroyave F; Halpert K; España Peña JA; Salazar Uribe JC Stem Cell Res Ther; 2024 May; 15(1):146. PubMed ID: 38764070 [TBL] [Abstract][Full Text] [Related]
2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557 [TBL] [Abstract][Full Text] [Related]
3. Mesenchymal stromal cells as treatment or prophylaxis for acute or chronic graft-versus-host disease in haematopoietic stem cell transplant (HSCT) recipients with a haematological condition. Fisher SA; Cutler A; Doree C; Brunskill SJ; Stanworth SJ; Navarrete C; Girdlestone J Cochrane Database Syst Rev; 2019 Jan; 1(1):CD009768. PubMed ID: 30697701 [TBL] [Abstract][Full Text] [Related]
4. Efficacy and Safety of Mesenchymal Stem Cell Therapy in Patients with Acute Myocardial Infarction: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Yu J; Zhang RF; Mao YL; Zhang H Curr Stem Cell Res Ther; 2022; 17(8):793-807. PubMed ID: 34397334 [TBL] [Abstract][Full Text] [Related]
5. A Systematic Review and Meta-Analysis: Safety and Efficacy of Mesenchymal Stem Cells Therapy for Heart Failure. Shen T; Xia L; Dong W; Wang J; Su F; Niu S; Wang Q; Fang Y Curr Stem Cell Res Ther; 2021; 16(3):354-365. PubMed ID: 32867655 [TBL] [Abstract][Full Text] [Related]
6. Clinical efficacy on glycemic control and safety of mesenchymal stem cells in patients with diabetes mellitus: Systematic review and meta-analysis of RCT data. He J; Kong D; Yang Z; Guo R; Amponsah AE; Feng B; Zhang X; Zhang W; Liu A; Ma J; O'Brien T; Cui H PLoS One; 2021; 16(3):e0247662. PubMed ID: 33705413 [TBL] [Abstract][Full Text] [Related]
8. Relative efficacy and safety of mesenchymal stem cells for osteoarthritis: a systematic review and meta-analysis of randomized controlled trials. Tian X; Qu Z; Cao Y; Zhang B Front Endocrinol (Lausanne); 2024; 15():1366297. PubMed ID: 38915896 [TBL] [Abstract][Full Text] [Related]
9. Decadal analysis of efficacy and safety profiles of mesenchymal stem cells from varied sources in knee osteoarthritis patients: A systematic review and network meta-analysis. Tang X; Huang H; Hao L Exp Gerontol; 2024 Jul; 192():112460. PubMed ID: 38772192 [TBL] [Abstract][Full Text] [Related]
10. Serious Adverse Events Have Not Been Reported with Spinal Intrathecal Injection of Mesenchymal Stem Cells: A Systematic Review. Barmada A; Sharan J; Band N; Prodromos C Curr Stem Cell Res Ther; 2023; 18(6):829-833. PubMed ID: 35980065 [TBL] [Abstract][Full Text] [Related]
11. Safety, efficacy and biomarkers analysis of mesenchymal stromal cells therapy in ARDS: a systematic review and meta-analysis based on phase I and II RCTs. Wang J; Luo F; Suo Y; Zheng Y; Chen K; You D; Liu Y Stem Cell Res Ther; 2022 Jun; 13(1):275. PubMed ID: 35752865 [TBL] [Abstract][Full Text] [Related]
12. Mesenchymal Stem Cells for the Treatment of Spinal Cord Injury in Rat Models: A Systematic Review and Network Meta-Analysis. Wang Y; Ding Y; Guo C Cell Transplant; 2024; 33():9636897241262992. PubMed ID: 38910431 [TBL] [Abstract][Full Text] [Related]
13. Intra-Articular Mesenchymal Stromal Cell Injections Are No Different From Placebo in the Treatment of Knee Osteoarthritis: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Dai W; Leng X; Wang J; Shi Z; Cheng J; Hu X; Ao Y Arthroscopy; 2021 Jan; 37(1):340-358. PubMed ID: 33098949 [TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of mesenchymal stem cells therapy in COVID-19 patients: a systematic review and meta-analysis of randomized controlled trials. Lu W; Yan L; Tang X; Wang X; Du J; Zou Z; Li L; Ye J; Zhou L J Transl Med; 2024 Jun; 22(1):550. PubMed ID: 38851730 [TBL] [Abstract][Full Text] [Related]
15. Belimumab combined with standard therapy does not increase adverse effects compared with a control treatment: A systematic review and meta-analysis of randomised controlled trials. Xu Y; Xu JW; Wang YJ; Tung TH; Chien CW Int Immunopharmacol; 2022 Aug; 109():108811. PubMed ID: 35512563 [TBL] [Abstract][Full Text] [Related]
16. Effect and safety of mesenchymal stem cells for patients with COVID-19: Systematic review and meta-analysis with trial sequential analysis. Zhang Z; Shao S; Liu X; Tong Z J Med Virol; 2023 Apr; 95(4):e28702. PubMed ID: 36964933 [TBL] [Abstract][Full Text] [Related]
17. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review. Chai KL; Valk SJ; Piechotta V; Kimber C; Monsef I; Doree C; Wood EM; Lamikanra AA; Roberts DJ; McQuilten Z; So-Osman C; Estcourt LJ; Skoetz N Cochrane Database Syst Rev; 2020 Oct; 10():CD013600. PubMed ID: 33044747 [TBL] [Abstract][Full Text] [Related]
19. Intra-articular injection of mesenchymal stem cells for clinical outcomes and cartilage repair in osteoarthritis of the knee: a meta-analysis of randomized controlled trials. Kim SH; Ha CW; Park YB; Nam E; Lee JE; Lee HJ Arch Orthop Trauma Surg; 2019 Jul; 139(7):971-980. PubMed ID: 30756165 [TBL] [Abstract][Full Text] [Related]
20. Mesenchymal Stem Cells on Mortality in COVID-19 Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Qin J; Wang G; Han D Stem Cell Rev Rep; 2024 May; 20(4):931-937. PubMed ID: 38427315 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]